Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostics legislation

This article was originally published in The Gray Sheet

Executive Summary

A Medicare reform bill for in vitro diagnostic tests could be introduced in Congress by the end of the month. AdvaMed and other interested groups are close to finding a sponsor on the Hill for the legislation, which will focus on modernizing the current Clinical Laboratory Fee Schedule to make it more rewarding to innovative new tests, according to a rep from the medical device trade association. The bill will follow some of the recommendations included in a Lewin Group report on "The Value of Diagnostics," released in July 2005 (1"The Gray Sheet" Aug. 1, 2005, p. 9)...
Advertisement

Related Content

AdvaMed Cites Lewin Group Study In Call For Updated CMS Diagnostic System
AdvaMed Cites Lewin Group Study In Call For Updated CMS Diagnostic System
Advertisement
UsernamePublicRestriction

Register

MT023309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel